DePuy Synthes
DePuy Synthes
| Type | Subsidiary |
|---|---|
| Industry | Medical Devices |
| Products | Orthopedic and Neurosurgical Devices |
| Website | [DePuy Synthes Official website] |
DePuy Synthes is a global leader in the design, manufacture, and supply of orthopedic and neurosurgical devices. It is a subsidiary of Johnson & Johnson, one of the largest healthcare companies in the world.
History[edit]
DePuy was founded in 1895 by Revra DePuy in Warsaw, Indiana. The company initially focused on manufacturing fiber splints to set fractures. Over the years, DePuy expanded its product line to include a wide range of orthopedic devices.
In 1998, DePuy was acquired by Johnson & Johnson, further expanding its reach and capabilities in the medical device industry. In 2012, DePuy merged with Synthes, a Swiss company known for its trauma products, to form DePuy Synthes.
Products and Services[edit]
DePuy Synthes offers a comprehensive portfolio of products and services for the treatment of musculoskeletal conditions. These include:
- Joint Reconstruction: Products for hip, knee, and shoulder replacement surgeries.
- Trauma: Devices for the surgical treatment of bone fractures.
- Spine: Solutions for spinal disorders, including degenerative disc disease and scoliosis.
- Sports Medicine: Products for the repair and reconstruction of soft tissue injuries.
- Craniomaxillofacial: Devices for the treatment of conditions affecting the skull, jaw, and face.
- Power Tools: Surgical power tools for orthopedic procedures.
Research and Development[edit]
DePuy Synthes is committed to advancing the field of orthopedic and neurosurgical care through continuous research and development. The company collaborates with leading surgeons and researchers to develop innovative solutions that improve patient outcomes.
Corporate Responsibility[edit]
As part of Johnson & Johnson, DePuy Synthes adheres to high standards of corporate responsibility. The company is dedicated to ethical business practices, sustainability, and improving global health.
See Also[edit]
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
